Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
Vedanta Biosciences has raised $3.9M in total funding. The most recent round was Grant. The last funding was announced in April 2024.
Vedanta Biosciences's investors include Bill & Melinda Gates Foundation, Pfizer, Korea Investment & Securities, Salica, Oxford Finance LLC.
Vedanta Biosciences is headquartered in Cambridge, United States.
Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
Vedanta Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vedanta Biosciences — Funding & Investors." VCBacked, April 30, 2024, https://www.vcbacked.co/company/vedanta-biosciences. Accessed July 21, 2026.
VCBacked. (2024). Vedanta Biosciences — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/vedanta-biosciences
{{cite web |title=Vedanta Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/vedanta-biosciences |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated